Eszopiclone 3mg Tablets

Eszopiclone 3mg Tablets: Insomnia Treatment

Eszopiclone 3mg Tablets is a prescription medication used to treat insomnia, including difficulty falling asleep or staying asleep. Eszopiclone is also marketed under the trade name Lunesta. It belongs to a group of medicines known as non-benzodiazepine sedative-hypnotics. The medication works by reducing activity in the brain, helping the body enter and maintain sleep more effectively. Treatment should always be used according to the dosage and duration recommended by a healthcare professional.

Formulation and Composition

Eszopiclone 3mg Tablets contain 3 milligrammes of eszopiclone as the active ingredient in each tablet. Eszopiclone tablets are intended for oral administration and are generally film-coated and round. The exact colour, markings, and inactive ingredients may vary according to the manufacturer. The 3mg strength is one of the available strengths of eszopiclone and is generally prescribed when a healthcare professional determines that a higher dose is appropriate.

The tablet is formulated for immediate release after administration. Patients should check the product packaging and dispensing label to confirm the correct strength before taking the medication.

Guide to Safe Use

Eszopiclone 3mg Tablets may be prescribed to adults who have difficulty falling asleep, staying asleep, or both, when a healthcare provider considers this strength appropriate. Treatment generally begins with a lower dose, and the dose may be adjusted by a healthcare provider according to the patient’s response, age, other medications, and overall medical condition. The maximum recommended adult dose is 3mg once daily immediately before bedtime.

Patients should not increase their dose without medical advice. Taking Eszopiclone with or immediately after a heavy or high-fat meal can delay its absorption and may reduce how quickly it helps with sleep. For this reason, the medication should be taken according to the instructions supplied by the prescribing healthcare professional.

Management

As directed, take Eszopiclone orally immediately before going to bed. The tablet should be swallowed with water and should not be taken earlier in the evening when the patient still needs to remain active.

Patients should only take the medication when they are able to remain in bed for approximately 7-8 hours before they need to become active again. Taking it when insufficient sleep time is available can increase the risk of next-day drowsiness, reduced alertness, impaired coordination, and difficulty concentrating.

Do not take more than one dose during the same night. If a dose is missed and there is not enough time remaining for a full night’s sleep, the missed dose should generally be skipped rather than taken late.

Action Mechanism

Eszopiclone produces its sedative effect by interacting with receptors in the brain associated with gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter. By enhancing GABA-related activity, the medication slows certain forms of brain activity and supports the transition into sleep.

This action can help reduce the amount of time required to fall asleep and may help some patients remain asleep for longer. Eszopiclone should nevertheless be used only as prescribed because its effects on alertness can continue after waking, particularly with the 3mg strength.

Potential Responses and Safety Measures

Common side effects associated with Eszopiclone can include an unpleasant or bitter taste, dry mouth, headache, dizziness, and drowsiness. Some people may also experience reduced alertness or difficulty concentrating the following day.

More serious reactions can occur. Eszopiclone has been associated with complex sleep behaviours such as sleepwalking, preparing or eating food, making phone calls, or performing other activities while not fully awake. Patients may have no memory of these activities afterwards. If complex sleep behaviour occurs, the medication should be stopped and medical advice should be obtained promptly.

Serious allergic reactions, including swelling of the face, tongue, or throat and difficulty breathing, require urgent medical attention. Patients should also inform their healthcare provider if they experience significant changes in mood, unusual behaviour, worsening depression, memory problems, or severe confusion.

Before beginning Eszopiclone, patients should tell their healthcare provider about liver problems, breathing disorders, previous problems with alcohol or drug misuse, mental health conditions, pregnancy, breastfeeding, and any other prescription or non-prescription medicines they use.

Cautions

Eszopiclone 3mg Tablets can cause physical or psychological dependence, particularly when taken differently from the prescribed instructions or for prolonged periods. Patients should therefore use only the amount prescribed by their healthcare professional and should not share the medication with another person.

Alcohol should be avoided while taking Eszopiclone because it can increase sedation and impairment. Other central nervous system depressants, including certain opioids, benzodiazepines, sedating antihistamines, and other sleep medicines, may also increase drowsiness and breathing or coordination problems. A healthcare professional should be consulted before combining Eszopiclone with medicines that cause sedation.

The 3mg dose can cause next-day impairment even when taken as directed. Patients should be particularly cautious about driving, operating machinery, or performing activities requiring complete alertness the following day.

Stopping Eszopiclone suddenly after regular use may cause withdrawal symptoms or temporary rebound insomnia. Patients who have been taking the medication regularly should discuss discontinuation with their healthcare provider rather than changing treatment on their own.

Keeping

Eszopiclone should be stored at controlled room temperature and protected from excessive heat and moisture. Keep the tablets in their original or properly labelled container and ensure that the container remains securely closed.

Keep Eszopiclone away from children, pets, and anyone for whom the medication was not prescribed. Because misuse is possible, unwanted or expired tablets should be disposed of using an appropriate medication disposal method rather than being kept for future use.

In conclusion

Eszopiclone 3mg Tablets are a prescription treatment for insomnia that can help patients who have difficulty falling asleep or remaining asleep. The medication should be taken only immediately before bedtime and only when sufficient time is available for a full night’s sleep. Because the 3mg strength can cause next-day impairment and other adverse effects, patients should carefully follow their healthcare provider’s instructions and avoid taking more than prescribed.

Patients experiencing persistent sleep problems, unusual sleep behaviours, severe side effects, or difficulty stopping treatment should consult a healthcare professional for appropriate evaluation and continued management.

Furthermore, You may read more about the medication here.